MoneyWorks4Me

Medicamen Biotech informs about details of related party transactions

23 Nov 2022 Evaluate

Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Medicamen Biotech has informed that it enclosed details of related party transactions on consolidated basis for the half year ended on September 30, 2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..